Sulfuric Acid

Sulfuric Acid

SCHEMBL30331189

O=S(=O)(O)CCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.O=S(=O)([O-])O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP51cyp51Acyp51c

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.47
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
TRAP1 Q12931 1/20 0.38
CHRNA7 P36544 8/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35255 0.93 HIF1A (0.44) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Trifluoromethanesulfonic Acid SCHEMBL34579 0.89 ALDH1A1 (0.40) HIF1AALDH1A1CYP1A2CYP2D6TSHR
SCHEMBL34778 0.89 HIF1A (0.42) HIF1AALDH1A1CYP1A2CYP2D6TSHR
SCHEMBL2230521 0.85 ALDH1A1 (0.38) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Trifluoromethanesulfonic Acid SCHEMBL34640 0.85 ALDH1A1 (0.39) HIF1AALDH1A1CYP1A2CYP2D6TSHR
SCHEMBL2922386 0.84 HIF1A (0.52) HIF1AALDH1A1CYP1A2CYP2D6TSHR
SCHEMBL34197 0.81 TRAP1 (0.39) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Trifluoroacetic Acid SCHEMBL34543 0.81 ALDH1A1 (0.41) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Sulfuric Acid SCHEMBL699062 0.80 HIF1A (0.56) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Sulfuric Acid SCHEMBL20975185 0.79 HIF1A (0.50) HIF1AALDH1A1CYP1A2CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12528929-B2 Depolymerization of polymers with ester, ether and carbonate linkages using acidic ionic liquid (AIL) catalyst COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN RESGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) 2026-01-20 US claimed
US-20230078491-A1 DEPOLYMERIZATION OF POLYMERS WITH ESTER, ETHER AND CARBONATE LINKAGES USING ACIDIC IONIC LIQUID (AIL) CATALYST COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) 2023-03-16 US claimed
US-12528929-B2 Depolymerization of polymers with ester, ether and carbonate linkages using acidic ionic liquid (AIL) catalyst COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN RESGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) 2026-01-20 US disclosed
US-20230078491-A1 DEPOLYMERIZATION OF POLYMERS WITH ESTER, ETHER AND CARBONATE LINKAGES USING ACIDIC IONIC LIQUID (AIL) CATALYST COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) 2023-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528929-B2 Depolymerization of polymers with ester, ether and carbonate linkages using acidic ionic liquid (AIL) catalyst PDK1, PC, PHYKPL HIF1A 650/4885ALDH1A1 1540/4885CYP1A2 2898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.